FDA panel backs Alzheimer's drug that can reportedly slow cognitive decline

The FDA has approved a new medication aimed at slowing the effects of Alzheimer's disease. An advisor claims the drug's benefits outweigh its risks, potentially delaying cognitive decline by several months. However, experts are divided on whether patients or their families will notice a significant difference.

What are the risks associated with the new Alzheimer's medication?

In what ways might the new medication impact patients and their loved ones?